1. Home
  2. SNOA vs SQFT Comparison

SNOA vs SQFT Comparison

Compare SNOA & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • SQFT
  • Stock Information
  • Founded
  • SNOA 1999
  • SQFT 1999
  • Country
  • SNOA United States
  • SQFT United States
  • Employees
  • SNOA N/A
  • SQFT N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • SQFT Real Estate Investment Trusts
  • Sector
  • SNOA Health Care
  • SQFT Real Estate
  • Exchange
  • SNOA Nasdaq
  • SQFT Nasdaq
  • Market Cap
  • SNOA 6.4M
  • SQFT 6.2M
  • IPO Year
  • SNOA 2007
  • SQFT 2020
  • Fundamental
  • Price
  • SNOA $2.90
  • SQFT $4.85
  • Analyst Decision
  • SNOA
  • SQFT
  • Analyst Count
  • SNOA 0
  • SQFT 0
  • Target Price
  • SNOA N/A
  • SQFT N/A
  • AVG Volume (30 Days)
  • SNOA 25.5K
  • SQFT 5.1K
  • Earning Date
  • SNOA 06-17-2025
  • SQFT 08-13-2025
  • Dividend Yield
  • SNOA N/A
  • SQFT N/A
  • EPS Growth
  • SNOA N/A
  • SQFT N/A
  • EPS
  • SNOA N/A
  • SQFT N/A
  • Revenue
  • SNOA $14,288,000.00
  • SQFT $18,260,398.00
  • Revenue This Year
  • SNOA $38.54
  • SQFT $23.63
  • Revenue Next Year
  • SNOA N/A
  • SQFT N/A
  • P/E Ratio
  • SNOA N/A
  • SQFT N/A
  • Revenue Growth
  • SNOA 12.20
  • SQFT N/A
  • 52 Week Low
  • SNOA $1.75
  • SQFT $4.19
  • 52 Week High
  • SNOA $9.37
  • SQFT $8.77
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 38.85
  • SQFT 34.89
  • Support Level
  • SNOA $2.81
  • SQFT $4.19
  • Resistance Level
  • SNOA $3.45
  • SQFT $4.57
  • Average True Range (ATR)
  • SNOA 0.13
  • SQFT 0.19
  • MACD
  • SNOA -0.05
  • SQFT 0.01
  • Stochastic Oscillator
  • SNOA 10.77
  • SQFT 30.65

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: